Qubio NeurocloudR

At Qubio we develop AI-assisted software for automatic and advanced neuroimaging analysis: Neurocloud, a CE marked tool for quantifying biomarkers in neurodegenerative diseases, which quickly, accurately and effectively helps the doctor (radiologist, neurologist and nuclear medicine doctor with PET, SPECT and MRI imaging) in the diagnosis and follow-up of the patient providing a complete report of the results in a few minutes. Neurocloud stands out for its experience of use and its clinically validated results (CE marked and FDA in progress) that help in the early diagnosis and monitoring of neurological diseases such as Multiple Sclerosis, Epilepsy, Parkinsons, Alzheimers, etc....

Nuclear medicine,resonance magnetic imaging,neuroimaging,computer aided diagnostics,deep learning,artificial intelligence,cloud computing,radiology,and neurology

Qubio neurocloudr operates in the Medical equipment manufacturing industry.

Qubio neurocloudr's revenue is 11m - 100m

Qubio neurocloudr has 11 - 50 employees.